Circulating Vascular Endothelial Growth Factor (VEGF) Levels in Advanced Stage Cancer Patients Compared to Normal Controls and Diabetes Mellitus Patients with Critical Ischemia
Anti-angiogenic therapy is emerging as a valuable tool in the treatment of patients with cancer. As VEGF is a central target in anti-angiogenic therapy, its levels in the circulation might be relevant in selecting tumor types or patients likely to respond to this treatment. Additional VEGF has bee...
Main Authors: | Yoka H. Kusumanto, Coby Meijer, Wendy Dam, Nanno H. Mulder, Geke A.P. Hospers |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2007-12-01
|
Series: | Drug Target Insights |
Subjects: | |
Online Access: | https://journals.aboutscience.eu/index.php/dti/article/view/2025 |
Similar Items
-
Circulating Vascular Endothelial Growth Factor (VEGF) Levels in Advanced Stage Cancer Patients Compared to Normal Controls and Diabetes Mellitus Patients with Critical Ischemia
by: Yoka H. Kusumanto, et al.
Published: (2007-01-01) -
by: Yoka H. Kusumanto, et al.
Published: (2007-01-01) -
Circulating Vascular Endothelial Growth Factor (VEGF) Levels in Advanced Stage Cancer Patients Compared to Normal Controls and Diabetes Mellitus Patients with Critical Ischemia
by: Yoka H. Kusumanto, et al.
Published: (2007-01-01) -
Influence of autotransplantation of bone marrow aspirate on VEGF expression level in the ischemic muscle and VEGF concentration in blood of patients with chronic lower limb ischemia of the III degree in different age groups
by: Shkuropat V.M.
Published: (2009-01-01) -
VEGF receptor targeted imaging of angiogenic response to limb ischemia in diabetic vs. non-diabetic Yucatan minipigs
by: Lynne L. Johnson, et al.
Published: (2020-05-01)